SCHEMBL6475415

SCHEMBL6475415

CC([O])C(=O)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6218904 0.78
SCHEMBL268874 0.76
SCHEMBL1397144 0.76 CA1 (0.35)
SCHEMBL5493506 0.76 L3MBTL1 (0.32)
SCHEMBL15431005 0.76 L3MBTL1 (0.32)
SCHEMBL1605045 0.73
SCHEMBL330404 0.73 ALDH1A1 (0.32)
SCHEMBL11360667 0.73 CYP2C19 (0.37)
SCHEMBL7620432 0.73
SCHEMBL15370335 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030119785-A1 Vitronectin receptor antagonists, their preparation and use HOECHST AKTIENGESELLSCHAFT AND GENENTECH INC. 2003-06-26 US claimed
US-20030027807-A1 Vitronectin receptor antagonists, their preparation and their use GENENTECH, INC. AND HOECHST AKTIENGESELLSCHAFT 2003-02-06 US claimed
US-20010011087-A1 Vitronectin receptor antagonists, their preparation and their use WEHNER VOLKMAR (DE) 2001-08-02 US claimed
US-6218387-B1 AS INHIBITORS OF BONE RESORPTION BY OSTEOCLASTS, FOR INHIBITING TUMOR GROWTH OR TUMOR METASTASIS, INHIBITING INFLAMMATION, OR FOR TREATMENT OR PROPHYLAXIS OF CARDIOVASCULAR DISEASES, NEUROPATHIES OR RETINOPATHIES HOECHST AKTIENGESELLSCHAFT (DE) 2001-04-17 US claimed
US-6207663-B1 AS INHIBITORS OF BONE RESORPTION, TUMOR GROWTH, TUMOR METASTASIS, OR INFLAMMATION, OR FOR THE TREATMENT OR PROPHYLAXIS OF CARDIOVASCULAR DISORDERS, NEPHROPATHIES OR RETINOPATHIES HOECHST ATKIENGESELLSCHAFT (DE) 2001-03-27 US claimed
EP-0854145-A2 Vitronectin receptor antagonists, their production and their use HOECHST AKTIENGESELLSCHAFT (DE) 1998-07-22 EP claimed
EP-0854140-A2 Vitronectin receptor antagonists, their production and their use HOECHST AKTIENGESELLSCHAFT (DE) 1998-07-22 EP claimed
US-6867208-B2 Vitronectin receptor antagonists, their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 2005-03-15 US disclosed
US-20030119785-A1 Vitronectin receptor antagonists, their preparation and use HOECHST AKTIENGESELLSCHAFT AND GENENTECH INC. 2003-06-26 US disclosed
US-20030027807-A1 Vitronectin receptor antagonists, their preparation and their use GENENTECH, INC. AND HOECHST AKTIENGESELLSCHAFT 2003-02-06 US disclosed
US-6482821-B2 ANTIINFLAMMATORY AGENTS; ANTITUMOR AGENTS; CARDIOVACULAR DISORDERS HOECHST AKTIENGELLSCHAFT (DE) 2002-11-19 US disclosed
US-6387895-B1 BONE DISORDERS; CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 2002-05-14 US disclosed
US-20010011087-A1 Vitronectin receptor antagonists, their preparation and their use WEHNER VOLKMAR (DE) 2001-08-02 US disclosed
US-6218387-B1 AS INHIBITORS OF BONE RESORPTION BY OSTEOCLASTS, FOR INHIBITING TUMOR GROWTH OR TUMOR METASTASIS, INHIBITING INFLAMMATION, OR FOR TREATMENT OR PROPHYLAXIS OF CARDIOVASCULAR DISEASES, NEUROPATHIES OR RETINOPATHIES HOECHST AKTIENGESELLSCHAFT (DE) 2001-04-17 US disclosed
US-6207663-B1 AS INHIBITORS OF BONE RESORPTION, TUMOR GROWTH, TUMOR METASTASIS, OR INFLAMMATION, OR FOR THE TREATMENT OR PROPHYLAXIS OF CARDIOVASCULAR DISORDERS, NEPHROPATHIES OR RETINOPATHIES HOECHST ATKIENGESELLSCHAFT (DE) 2001-03-27 US disclosed
US-6011045-A Vitronectin receptor antagonists, their preparation and their use HOECHST AKTIENGESELLSCHAFT 2000-01-04 US disclosed
US-5990145-A Vitronectin receptor antagonists, their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1999-11-23 US disclosed
EP-0854145-A2 Vitronectin receptor antagonists, their production and their use HOECHST AKTIENGESELLSCHAFT (DE) 1998-07-22 EP disclosed
EP-0854140-A2 Vitronectin receptor antagonists, their production and their use HOECHST AKTIENGESELLSCHAFT (DE) 1998-07-22 EP disclosed
US-4448776-A Method of using certain substituted aliphatic secondary amines or their salts for easing breathing BUCHER KARL (CH) 1984-05-15 US disclosed